Valor del «test de bipedestación» en el diagnóstico y la evaluación de la respuesta al tratamiento con bloqueadores beta en el síndrome de QT largo / Value of the 'standing test' in the diagnosis and evaluation of beta-blocker therapy response in long QT syndrome

Introducción y objetivos: Los pacientes con síndrome de QT largo (SQTL) tienen una adaptación anormal del QT a los cambios bruscos de la frecuencia cardiaca producidos con la bipedestación. Este trabajo estudia la utilidad del test de bipedestación en una cohorte de pacientes con SQTL y evalúa si el fenómeno de «mala adaptación» del QT se normaliza con el tratamiento con bloqueadores beta. Métodos: Se realizó un electrocardiograma basal y otro inmediatamente tras la bipedestación a 36 pacientes con SQTL (6 [17%] con QTL1, 20 [56%] con QTL2, 3 [8%] con QTL7 y 7 [19%] con genotipo no identificado) y 41 controles. Se midió el intervalo QT corregido (QTc) basal (QTcdecúbito) y tras la bipedestación (QTcbipedestación) y el incremento del QTc (ΔQTc = QTcbipedestación - QTcdecúbito). Se repitió el test en 26 de los pacientes bajo tratamiento con bloqueadores beta. Resultados: El QTcbipedestación y el ΔQTc fueron mayores en el grupo de SQTL que en el grupo control (QTcbipedestación, 528 ± 46 frente a 420 ± 15 ms; p < 0,0001; ΔQTc, 78 ± 40 frente a 8 ± 13 ms; p < 0,0001). No hubo diferencias significativas entre los pacientes con QTL1 y QTL2. Los pacientes con SQTL presentaron patrones típicos del segmento ST-onda T tras la bipedestación. Las curvas receiver operating characteristic del QTcbipedestación y ΔQTc mostraron un incremento significativo del valor diagnóstico comparadas con la del QTcdecúbito(área bajo la curva de ambos, 0,99 frente a 0,85; p < 0,001). El tratamiento con bloqueadores beta atenuó la respuesta a la bipedestación de los pacientes con SQTL (en tratamiento, QTcbipedestación, 440 ± 32 ms [p < 0,0001] y ΔQTc, 14 ± 16 ms [p < 0,0001]). Conclusiones: La evaluación del intervalo QTc tras la bipedestación proporciona un alto rendimiento diagnóstico y podría ser de gran utilidad en la monitorización del tratamiento con bloqueadores beta en los pacientes con SQTL (AU)

Introduction and objectives: Patients with congenital long QT syndrome (LQTS) have an abnormal QT adaptation to sudden changes in heart rate provoked by standing. The present study sought to evaluate the standing test in a cohort of LQTS patients and to assess if this QT maladaptation phenomenon is ameliorated by beta-blocker therapy. Methods: Electrographic assessments were performed at baseline and immediately after standing in 36 LQTS patients (6 LQT1 [17%], 20 LQT2 [56%], 3 LQT7 [8%], 7 unidentified-genotype patients [19%]) and 41 controls. The corrected QT interval (QTc) was measured at baseline (QTcsupine) and immediately after standing (QTcstanding); the QTc change from baseline (ΔQTc) was calculated as QTcstanding - QTcsupine. The test was repeated in 26 patients receiving beta-blocker therapy. Results: Both QTcstanding and ΔQTc were significantly higher in the LQTS group than in controls (QTcstanding, 528 ± 46 ms vs 420 ± 15 ms, P < .0001; ΔQTc, 78 ± 40 ms vs 8 ± 13 ms, P < .0001). No significant differences were noted between LQT1 and LQT2 patients. Typical ST-T wave patterns appeared after standing in LQTS patients. Receiver operating characteristic curves of QTcstanding and ΔQTc showed a significant increase in diagnostic value compared with the QTcsupine (area under the curve for both, 0.99 vs 0.85; P < .001). Beta-blockers attenuated the response to standing in LQTS patients (QTcstanding, 440 ± 32 ms, P < .0001; ΔQTc, 14 ± 16 ms, P < .0001). Conclusions: Evaluation of the QTc after the simple maneuver of standing shows a high diagnostic performance and could be important for monitoring the effects of beta-blocker therapy in LQTS patients (AU)

Value of the "Standing Test" in the Diagnosis and Evaluation of Beta-blocker Therapy Response in Long QT Syndrome.

INTRODUCTION AND OBJECTIVES: Patients with congenital long QT syndrome (LQTS) have an abnormal QT adaptation to sudden changes in heart rate provoked by standing. The present study sought to evaluate the standing test in a cohort of LQTS patients and to assess if this QT maladaptation phenomenon is ameliorated by beta-blocker therapy. METHODS: Electrographic assessments were performed at baseline and immediately after standing in 36 LQTS patients (6 LQT1 [17%], 20 LQT2 [56%], 3 LQT7 [8%], 7 unidentified-genotype patients [19%]) and 41 controls. The corrected QT interval (QTc) was measured at baseline (QTcsupine) and immediately after standing (QTcstanding); the QTc change from baseline (ΔQTc) was calculated as QTcstanding - QTcsupine. The test was repeated in 26 patients receiving beta-blocker therapy. RESULTS: Both QTcstanding and ΔQTc were significantly higher in the LQTS group than in controls (QTcstanding, 528 ± 46ms vs 420 ± 15ms, P < .0001; ΔQTc, 78 ± 40ms vs 8 ± 13ms, P < .0001). No significant differences were noted between LQT1 and LQT2 patients. Typical ST-T wave patterns appeared after standing in LQTS patients. Receiver operating characteristic curves of QTcstanding and ΔQTc showed a significant increase in diagnostic value compared with the QTcsupine (area under the curve for both, 0.99 vs 0.85; P < .001). Beta-blockers attenuated the response to standing in LQTS patients (QTcstanding, 440 ± 32ms, P < .0001; ΔQTc, 14 ± 16ms, P < .0001). CONCLUSIONS: Evaluation of the QTc after the simple maneuver of standing shows a high diagnostic performance and could be important for monitoring the effects of beta-blocker therapy in LQTS patients.

Fenotipo heterogéneo del síndrome de QT largo causado por la mutación KCNH2-H562R: importancia del estudio genético familiar / Heterogeneous phenotype of long QT Syndrome caused by the KCNH2-H562R Mutation: Importance of familial genetic testing

Introducción y objetivos: El síndrome de QT largo es una canalopatía hereditaria que se asocia a síncope y muerte súbita. La heterogeneidad fenotípica de esta enfermedad hace que el estudio genético sea fundamental para detectar a los sujetos con síndrome de QT largo oculto. En este trabajo se exponen las características de una familia con 13 portadores de la mutación missense KCNH2-H562R que afecta a la región del poro del canal HERG. Métodos: Se describió la mutación KCNH2-H562R en un varón de 65 años con intervalo QTc prolongado que presentó un episodio de torsade de pointes. Posteriormente, se identificaron 13 portadores de la mutación en la familia. Se realizó evaluación clínica, electrocardiograma y ecocardiograma a los portadores (edad, 48 ± 26 años; el 46% varones). Resultados: El QTc medio en los portadores fue de 493 ± 42 ms (3 [23%] mostraron QTc normal); 6 (46%) tuvieron síntomas (4, síncope; 1, muerte súbita; 1, muerte súbita resucitada [probando]). Durante el tratamiento con bloqueadores beta, 11 (92%) de los 12 portadores permanecieron asintomáticos a los 5 años de seguimiento (1 paciente requirió simpatectomía cardiaca izquierda). El acortamiento del QTc con bloqueadores beta fue de 50 ± 37 ms. Hubo 1 muerte súbita en un paciente que rechazó tratamiento con bloqueadores beta. Conclusiones: El estudio familiar es fundamental en la interpretación de los resultados de los tests genéticos en la actualidad. Este artículo describe el fenotipo variable y heterogéneo de una amplia familia portadora de la mutación KCNH2-H562R y destaca el papel del estudio genético en la identificación de los individuos en riesgo que se beneficiarían del tratamiento con bloqueadores beta (AU)

Introduction and objectives: Long QT syndrome is an inherited ion channelopathy that leads to syncope and sudden death. Because of the heterogeneous phenotype of this disease, genetic testing is fundamental to detect individuals with concealed long QT syndrome. In this study, we determined the features of a family with 13 carriers of the KCNH2-H562R missense mutation, which affects the pore region of the HERG channel. Methods: We identified the KCNH2-H562R mutation in a 65-year-old man with a prolonged QTc interval who had experienced an episode of torsade de pointes. Subsequently, a total of 13 mutation carriers were identified in the family. Carriers (age 48 [26] years; 46% males) underwent clinical evaluation, electrocardiography and echocardiography. Results: The mean (standard deviation) QTc in carriers was 493 (42) ms (3 [23%] showed normal QTc); 6 (46%) had symptoms (4, syncope; 1, sudden death; 1, aborted sudden death [proband]). While under treatment with beta-blockers, 11 of 12 carriers (92%) remained asymptomatic at 5 years of follow-up (1 patient required left cardiac sympathectomy). The QTc shortening with beta-blockers was 50 (37) ms. There was 1 sudden death in a patient who refused treatment. Conclusions: Family study is essential in the interpretation of a genetic testing result. This article describes the heterogeneous and variable phenotype of a large family with the KCNH2-H562R mutation and highlights the role of genetic study for the appropriate identification of at-risk individuals who would benefit from treatment (AU)

Diagnostic Approach to Unexplained Cardiac Arrest (from the FIVI-Gen Study).

Unexplained cardiac arrest (UCA) can be caused by low-penetrance genetic disorders. The aim of this cross-sectional study is to assess the usefulness of a new diagnostic protocol: Thirty-five patients were recruited from 9 Spanish centers. Electrocardiogram, echocardiogram, and coronary catheterization were used to rule out electrical or structural heart disease in all subjects. Patients underwent pharmacologic tests with epinephrine and flecainide, followed by assessment of family members using electrocardiogram and echocardiogram, and next-generation genetic sequencing to analyze 126 genes if all the other test results were negative. A firm diagnosis of channelopathy required phenotypic proof of the condition in unmasking tests, the presence of a pathogenic variant consistent with the phenotype observed, and/or co-segregation of the mutation found in a family member's phenotype. A firm diagnosis was made in 18 cases. The diagnoses were 7 Brugada syndrome, 5 catecholaminergic polymorphic ventricular tachycardia, 3 long QT syndrome, 2 early repolarization syndrome, and 1 short QT syndrome. Pharmacologic testing was the most frequent method of diagnosis. In 5 cases, the diagnosis was made based on positive genetic testing without phenotypic alterations. In conclusion, this sequential diagnostic protocol allows diagnoses to be made in approximately half of the UCA cases. These diagnoses are low clinical penetrance channelopathies. If interpreted carefully, genetic tests can be a useful tool for diagnosing UCA without a phenotype.

Heterogeneous Phenotype of Long QT Syndrome Caused by the KCNH2-H562R Mutation: Importance of Familial Genetic Testing.

INTRODUCTION AND OBJECTIVES: Long QT syndrome is an inherited ion channelopathy that leads to syncope and sudden death. Because of the heterogeneous phenotype of this disease, genetic testing is fundamental to detect individuals with concealed long QT syndrome. In this study, we determined the features of a family with 13 carriers of the KCNH2-H562R missense mutation, which affects the pore region of the HERG channel. METHODS: We identified the KCNH2-H562R mutation in a 65-year-old man with a prolonged QTc interval who had experienced an episode of torsade de pointes. Subsequently, a total of 13 mutation carriers were identified in the family. Carriers (age 48 [26] years; 46% males) underwent clinical evaluation, electrocardiography and echocardiography. RESULTS: The mean (standard deviation) QTc in carriers was 493 (42) ms (3 [23%] showed normal QTc); 6 (46%) had symptoms (4, syncope; 1, sudden death; 1, aborted sudden death [proband]). While under treatment with beta-blockers, 11 of 12 carriers (92%) remained asymptomatic at 5 years of follow-up (1 patient required left cardiac sympathectomy). The QTc shortening with beta-blockers was 50 (37) ms. There was 1 sudden death in a patient who refused treatment. CONCLUSIONS: Family study is essential in the interpretation of a genetic testing result. This article describes the heterogeneous and variable phenotype of a large family with the KCNH2-H562R mutation and highlights the role of genetic study for the appropriate identification of at-risk individuals who would benefit from treatment.

Identificación del nervio frénico con tomografía computarizada cardiaca multidetector / Phrenic nerve identification with cardiac multidetector computed tomography

La crioablación con balón de las venas pulmonares es una técnica novedosa que se ha demostrado útil para prevenir las recurrencias de la fibrilación auricular paroxística y persistente. Una de las complicaciones más relevantes del procedimiento es la parálisis del nervio frénico derecho. Se ha descrito recientemente la utilidad de la tomografía computarizada multidetector para localizar el recorrido de la arteria y el nervio frénico y predecir el riesgo de parálisis frénica durante la crioablación, según la distancia del paquete vasculonervioso frénico derecho al ostium de la vena pulmonar superior derecha. A 55 pacientes consecutivos con fibrilación auricular paroxística (media de edad 52±12 años) sometidos a crioablación con balón, se les realizó estudio previo con tomografía computarizada multidetector para medir el tamaño de las venas pulmonares. Se pudo identificar algún fragmento de la arteria pericardiofrénica derecha en 10 pacientes (20%), con una longitud media de 25 (7-68) mm (AU)

Cryoballoon ablation of the pulmonary veins is a new technique that has proven useful in preventing paroxysmal and persistent atrial fibrillation recurrence. One of the most serious complications of this method is right phrenic nerve palsy. The usefulness of multidetector computed tomography to locate the right phrenic nerve and artery and predict the risk of phrenic nerve palsy during cryoablation according to the distance between the right phrenic neurovascular bundle and the right superior pulmonary vein ostium has recently been described. Fifty-five consecutive patients with paroxysmal atrial fibrillation (52±12 years) underwent balloon cryoablation, following multidetector computed tomography to measure the pulmonary veins. We were able to identify segments of the right pericardiacophrenic artery (mean length 25mm [range 7-68mm]) in only 10 patients (20%) (AU)

[Phrenic nerve identification with cardiac multidetector computed tomography]. / Identificación del nervio frénico con tomografía computarizada cardiaca multidetector.

Cryoballoon ablation of the pulmonary veins is a new technique that has proven useful in preventing paroxysmal and persistent atrial fibrillation recurrence. One of the most serious complications of this method is right phrenic nerve palsy. The usefulness of multidetector computed tomography to locate the right phrenic nerve and artery and predict the risk of phrenic nerve palsy during cryoablation according to the distance between the right phrenic neurovascular bundle and the right superior pulmonary vein ostium has recently been described. Fifty-five consecutive patients with paroxysmal atrial fibrillation (52 ± 12 years) underwent balloon cryoablation, following multidetector computed tomography to measure the pulmonary veins. We were able to identify segments of the right pericardiacophrenic artery (mean length 25 mm [range 7-68 mm]) in only 10 patients (20%).

Effects of the location of myocardial infarction on the spectral characteristics of ventricular fibrillation.

BACKGROUND: The location of the myocardial infarction (MI) might modify the spectral characteristics of ventricular fibrillation (VF) in humans. OBJECTIVE: To evaluate the effect of the location of the infarcted area on the spectral parameters of VF. METHODS: Patients with chronic MI (29 anterior, 32 inferior) and induced VF during cardioverter defibrillator implant were retrospectively studied. Dominant frequency (f(d)), organization index (OI), and power of the harmonic peaks were calculated in the device-stored electrograms (EGM) during sinus rhythm (SR) and VF. RESULTS: The f(d) of the VF was not affected by the left ventricular ejection fraction (LVEF) or the MI location (anterior: 4.54 +/- 0.74 Hz, inferior: 4.77 +/- 0.48 Hz, n.s.). The OI was also similar in both groups. However, in patients with inferior MIs, normalized peak power at f(d) was higher (118.3 +/- 18.5 vs 100.6 +/- 28.2, P < 0.01) and the normalized peak power of the harmonics was lower than in the anterior MI group. The analysis of EGM during SR showed similar results. The size of the necrotic area and its distance to the recording electrode might partially explain these results. CONCLUSION: In our series, the spectral characteristics of the EGMs during VF showed significant differences depending on the MI localization. A higher fraction of energy (in the low-frequency region) was seen in inferior MIs, whereas the peak power at the harmonics increased in anterior MIs. A similar effect was seen during SR and VF, suggesting that it is caused by local electrophysiology abnormalities induced by the MI rather than by different intrinsic characteristics of the VF.

[Comparison of the degree of right atrial opacification seen on intracardiac echocardiography following femoral or antecubital injection of saline contrast]. / Comparación del grado de opacificación auricular derecha con ecocardiografía intracardiaca tras inyecciones femoral y antecubital de contraste salino.

It is thought that femoral injection of agitated saline contrast is better for detecting patent foramen ovale than antecubital injection mainly because of the nature of intraatrial flow where the venae cavae enter the heart. Our aim was to investigate the effect of the contrast injection site on the degree of right atrial opacification seen on intracardiac echocardiography. The degree of right atrial opacification after each femoral or antecubital injection of saline contrast was scored from 0-4 in 21 patients. It was shown that the degree of right atrial opacification was greater after femoral than antecubital injection (3.76 vs. 1.62; P<.001). Future studies comparing the two routes of saline contrast injection should control for the degree of right atrial opacification.

Comparación del grado de opacificación auricular derecha con ecocardiografía intracardiaca tras inyecciones femoral y antecubital de contraste salino / Comparison of the degree of right atrial opacification seen on intracardiac echocardiography following femoral or antecubital injection of saline contrast

Se asume que la superioridad de la inyección femoral de suero salino agitado para la detección del foramen oval permeable comparada con la antecubital se debe principalmente al efecto de las corrientes intrauriculares de la desembocadura de las cavas. Nos propusimos evaluar la influencia del lugar de inyección de contraste en el grado de opacificación auricular derecha en ecografía intracardiaca. Se puntuó de 0 a 4 el grado de opacificación obtenido tras inyecciones venosas por vía antecubital y femoral de contraste salino en 21 pacientes. Se comprobó que el grado de opacificación auricular derecha es mayor tras la inyección femoral que la antecubital (3,76 frente a 1,62; p < 0,001). Los futuros estudios que comparen ambas vías de inyección de salino deberían controlar el grado de opacificación auricular derecha (AU)

It is thought that femoral injection of agitated saline contrast is better for detecting patent foramen ovale than antecubital injection mainly because of the nature of intraatrial flow where the venae cavae enter the heart. Our aim was to investigate the effect of the contrast injection site on the degree of right atrial opacification seen on intracardiac echocardiography. The degree of right atrial opacification after each femoral or antecubital injection of saline contrast was scored from 0­4 in 21 patients. It was shown that the degree of right atrial opacification was greater after femoral than antecubital injection (3.76 vs. 1.62; P<.001). Future studies comparing the two routes of saline contrast injection should control for the degree of right atrial opacification (AU)

[Usefulness of incremental atrial pacing for evaluating the effectiveness of the ablation of the slow perinodal pathway]. / Utilidad de la estimulación auricular progresiva para evaluar la efectividad de la ablación de la vía lenta perinodal.

INTRODUCTION AND OBJECTIVES: To study the usefulness of incremental atrial pacing for evaluating the effect of radiofrequency catheter ablation on slow pathway conduction in patients with atrioventricular (AV) nodal reentrant tachycardia. METHODS: A prospective study was carried out in patients either with (i.e., AV nodal reentrant tachycardia group) or without (i.e., control group) inducible AV nodal reentrant tachycardia who were referred for electrophysiologic study. Incremental atrial pacing involved gradually decreasing the pacing cycle length until the PR interval exceeded the R-R interval (i.e., PR>RR) or AV nodal block occurred. The presence of dual anterograde AV nodal physiology was assessed during programmed atrial stimulation using standard criteria. In the AV nodal reentrant tachycardia group, electrophysiologic study was repeated 30 minutes after successful catheter ablation. RESULTS: In the AV nodal reentrant tachycardia group (n=85), 52 patients (61%) exhibited dual AV nodal physiology during programmed atrial stimulation and 66 (78%) had a PR>RR during incremental atrial pacing. In the control group, the corresponding proportions were 10/56 (18%) and 7/56 (12%), respectively. After successful slow pathway catheter ablation (81/85), 37/81 exhibited dual AV nodal physiology during programmed atrial stimulation while 1/81 had a PR>RR during incremental atrial pacing. The positive predictive value of successful slow pathway ablation for the absence of a PR>RR was 98%. CONCLUSIONS: Incremental atrial pacing demonstrated that the PR interval exceeded the R-R interval in the majority of patients with inducible AV nodal reentrant tachycardia. This technique could provide a fast and simple way of evaluating the effect of radiofrequency catheter ablation on slow pathway conduction.

Utilidad de la estimulación auricular progresiva para evaluar la efectividad de la ablación de la vía lenta perinodal / Usefulness of incremental atrial pacing for evaluating the effectiveness of the ablation of the slow perinodal pathway

Introducción y objetivos. Estudiar la utilidad de la estimulación auricular progresiva para evaluar el efecto de la ablación con catéter sobre la conducción por vía lenta en pacientes con taquicardia por reentrada nodal común. Métodos. Estudio prospectivo en pacientes remitidos para estudio electrofisiológico en los que se indujo taquicardia por reentrada nodal común, empleando como grupo control a los pacientes en los que no se indujo. La estimulación auricular progresiva se practicó mediante la disminución paulatina del ciclo de estimulación hasta obtener un intervalo PR > RR o bloqueo auriculoventricular. Durante la estimulación auricular programada se evaluó la presencia de doble fisiología nodal siguiendo el criterio estandarizado. En el grupo en que se indujo taquicardia se repitió el estudio electrofisiológico 30 min después de la ablación. Resultados. En el grupo con taquicardia por reentrada nodal común (n = 85), 52 pacientes (61%) mostraron criterios de doble vía nodal durante la estimulación auricular programada y 66 (78%) mantenían PR > RR durante la estimulación auricular progresiva. En el grupo control, la incidencia de estos criterios fue de 10/56 (18%) y 7/56 (12%), respectivamente. Tras la ablación eficaz de vía lenta (81/85), 37 mostraban doble vía nodal durante la estimulación auricular programada y uno tenía PR > RR durante estimulación auricular progresiva (valor predictivo positivo de la ausencia de PR > RR para ablación eficaz de vía lenta del 98%). Conclusiones. La estimulación auricular progresiva muestra un intervalo PR > RR en la mayoría de los pacientes en los que se induce taquicardia por reentrada nodal común y puede emplearse como un método sencillo y rápido para evaluar el efecto de las aplicaciones de radiofrecuencia sobre la conducción por vía lenta

Introduction and objectives. To study the usefulness of incremental atrial pacing for evaluating the effect of radiofrequency catheter ablation on slow pathway conduction in patients with atrioventricular (AV) nodal reentrant tachycardia. Methods. A prospective study was carried out in patients either with (i.e., AV nodal reentrant tachycardia group) or without (i.e., control group) inducible AV nodal reentrant tachycardia who were referred for electrophysiologic study. Incremental atrial pacing involved gradually decreasing the pacing cycle length until the PR interval exceeded the R-R interval (i.e., PR>RR) or AV nodal block occurred. The presence of dual anterograde AV nodal physiology was assessed during programmed atrial stimulation using standard criteria. In the AV nodal reentrant tachycardia group, electrophysiologic study was repeated 30 minutes after successful catheter ablation. Results. In the AV nodal reentrant tachycardia group (n=85), 52 patients (61%) exhibited dual AV nodal physiology during programmed atrial stimulation and 66 (78%) had a PR>RR during incremental atrial pacing. In the control group, the corresponding proportions were 10/56 (18%) and 7/56 (12%), respectively. After successful slow pathway catheter ablation (81/85), 37/81 exhibited dual AV nodal physiology during programmed atrial stimulation while 1/81 had a PR>RR during incremental atrial pacing. The positive predictive value of successful slow pathway ablation for the absence of a PR>RR was 98%. Conclusions. Incremental atrial pacing demonstrated that the PR interval exceeded the R­R interval in the majority of patients with inducible AV nodal reentrant tachycardia. This technique could provide a fast and simple way of evaluating the effect of radiofrequency catheter ablation on slow pathway conduction

Alternative explanations to the differences of femoral and brachial saline contrast injections for echocardiographic detection of patent foramen ovale.

Patent foramen ovale (PFO) of the interatrial septum is a cardiac foetal remnant, which frequent persistence in adulthood has important implications in a variety of clinical conditions. Echographic diagnosis of PFO is based on detection of interatrial shunt by means of contrast microbubbles identification after venous injection of a first-generation echographic contrast agent. Current recommendations propose venous femoral injection of contrast for enhanced echographic detection of PFO instead of venous brachial administration, as femoral injection has been shown to have higher sensitivity for PFO detection. Inferior vena cava inflow directed toward interatrial septum has been considered the explanation for increased sensitivity of femoral delivery of contrast. In the present paper, it is hypothesised that the main determinants of these differences between injection sites are technical factors related to right atrial contrast opacification and proper transient right atrial pressure rise, rather than intraatrial flow streaming. Effects of inferior vena cava inflow stream, although significant during foetal life, would be negligible after birth. Rationale and evidence, basis for further research, and practical implications leading to a simpler and safer routine technique for echographic detection of PFO are presented and discussed.

[Early heart rate increase does not predict the result of the head-up tilt test potentiated with nitroglycerin]. / El incremento temprano de la frecuencia cardíaca no predice el resultado de la prueba de basculación potenciada con nitroglicerina.

INTRODUCTION AND OBJECTIVES: The magnitude of the change in heart rate during the first few minutes of the head-up tilt test has been used to predict the test's result. The aim of this study was to investigate whether the heart rate increase during the head-up tilt test potentiated with nitroglycerin is related to the development of syncope. PATIENTS AND METHOD: The study included 158 consecutive patients with syncope, with stable sinus rhythm, and without structural cardiac disease who were undergoing a head-up tilt test with nitroglycerin. The heart rate increment induced by the tilt maneuver and by nitroglycerin administration was calculated, and its relationship to clinical variables and to the test's results was analyzed. RESULTS: The head-up tilt test gave positive results in 117 patients (74%). The heart rate was 68.7 (11.3) bpm in the decubitus position and 85.1 (15.4) bpm during the first 6 min of tilting. There was strong inverse correlation between the heart rate increase induced by tilting and age (r=--0.63; P<.001), but the increase (16.8 [9.3] bpm in patients with syncope versus 14.9 [11.3] bpm in those without; P=.3) did not predict the result of the test. The heart rate increase induced by nitroglycerin was also similar for patients with and without syncope during the pharmacologic phase of the test (27.3 [12.6] bpm and 26.7 (13.4) bpm, respectively; P=.8). CONCLUSIONS: The magnitude of the heart rate increase during the first few minutes of tilt-testing and after nitroglycerin administration is inversely related to age but does not predict the result of the head-up tilt test with nitroglycerin.

El incremento temprano de la frecuencia cardíaca no predice el resultado de la prueba de basculación potenciada con nitroglicerina / Early heart rate increase does not predict the result of the head-up tilt test potentiated with nitroglycerin

Introducción y objetivos. El incremento acentuado de la frecuencia cardíaca en los primeros minutos de la prueba de basculación ha sido utilizado como predictor del resultado final de ésta, en protocolos sin potenciación farmacológica o con isoproterenol. El objetivo del estudio es evaluar si este incremento se relaciona con la aparición de síncope durante la prueba de basculación potenciada con nitroglicerina. Pacientes y método. Análisis retrospectivo de 158 pacientes consecutivos sometidos a prueba de basculación potenciada con nitroglicerina por síncope, sin cardiopatía y en ritmo sinusal. Se calculó el incremento de la frecuencia cardíaca secundario a la basculación y el debido a la nitroglicerina, relacionándolos con las variables clínicas y el resultado de la prueba. Resultados. La prueba de basculación fue positiva en117 pacientes (74%). La frecuencia cardíaca pasó de68,7 ± 11,3 lat/min en decúbito a 85,1 ± 15,4 lat/min en los primeros 6 min pos-basculación. El incremento de frecuencia presentó una fuerte correlación negativa con la edad (r = -0,63; p < 0,001), pero no se relacionó significativamente con el resultado (16,8 ± 9,3 lat/min en el grupo con prueba positiva frente a 14,9 ± 11,3 en el negativo; p = 0,3). El aumento de la frecuencia cardíaca inducido por la nitroglicerina (27,3 ± 12,6 y 26,7 ± 13,4lat/min, respectivamente; p = 0,8) tampoco predijo el resultado del test durante la fase farmacológica. Conclusiones. Los incrementos de frecuencia cardíaca en los primeros minutos después de la basculación y la administración del fármaco se relacionan fundamentalmente con la edad y no tienen utilidad para predecir el resultado de la prueba de basculación potenciada con nitroglicerina (AU)

Introduction and objectives. The magnitude of the change in heart rate during the first few minutes of the head-up tilt test has been used to predict the test’s result. The aim of this study was to investigate whether the heart rate increase during the head-up tilt test potentiated with nitroglycerin is related to the development of syncope. Patients and method. The study included 158 consecutive patients with syncope, with stable sinus rhythm, and without structural cardiac disease who were undergoing a head-up tilt test with nitroglycerin. The heart rate increment induced by the tilt maneuver and by nitroglycerin administration was calculated, and its relationship to clinical variables and to the test’s results was analyzed. Results. The head-up tilt test gave positive results in117 patients (74%). The heart rate was 68.7 (11.3) bpm in the decubitus position and 85.1 (15.4) bpm during the first 6 min of tilting. There was strong inverse correlation between the heart rate increase induced by tilting and age (r = -0.63; P<.001), but the increase (16.8 [9.3] bp min patients with syncope versus 14.9 [11.3] bpm in those without; P=.3) did not predict the result of the test. The heart rate increase induced by nitroglycerin was also similar for patients with and without syncope during the pharmacologic phase of the test (27.3 [12.6] bpm and 26.7(13.4) bpm, respectively; P=.8). Conclusions. The magnitude of the heart rate increase during the first few minutes of tilt-testing and after nitroglycerin administration is inversely related to age but does not predict the result of the head-up tilt test with nitroglycerin (AU)

[A probabilistic model of cardiac electrical activity based on a cellular automata system]. / Desarrollo de un modelo probabilístico de la actividad eléctrica cardíaca basado en un autómata celular.

INTRODUCTION AND OBJECTIVES: Mathematical models of cardiac electrical activity may help to elucidate the electrophysiological mechanisms involved in the genesis of arrhythmias. The most realistic simulations are based on reaction-diffusion models and involve a considerable computational burden. The aim of this study was to develop a computer model of cardiac electrical activity able to simulate complex electrophysiological phenomena but free of the large computational demands required by other commonly used models. MATERIAL AND METHOD: A cellular automata system was used to model the cardiac tissue. Each individual unit had several discrete states that changed according to simple rules as a function of the previous state and the state of the neighboring cells. Activation was considered as a probabilistic process and was adjusted using restitution curves. In contrast, repolarization was modeled as a deterministic phenomenon. Cell currents in the model were calculated with a prototypical action potential that allowed virtual monopolar and bipolar electrograms to be simulated at any point in space. RESULTS: Reproducible flat activation fronts, propagation from a focal stimulus, and reentry processes that were stable and unstable in two dimensions (with their corresponding electrograms) were obtained. The model was particularly suitable for the simulation of the effects observed in curvilinear activation fronts. Fibrillatory conduction and stable rotors in two- and three-dimensional substrates were also obtained. CONCLUSIONS: The probabilistic cellular automata model was simple to implement and was not associated with a high computational burden. It provided a realistic simulation of complex phenomena of interest in electrophysiology.

Desarrollo de un modelo probabilístico de la actividad eléctrica cardíaca basado en un autómata celular / A probabilistic model of cardiac electrical activity based on a cellular automata system

Introducción y objetivos. La utilización de modelos matemáticos de activación y propagación del impulso ha mejorado la comprensión de diversos mecanismos electrofisiológicos involucrados en la génesis de las arritmias. Las simulaciones más realistas se basan en los modelos de reacción-difusión e implican una carga computacional muy elevada. El objetivo del estudio es desarrollar un modelo de activación eléctrica cardíaca por ordenador que permita simular fenómenos electrofisiológicos complejos y que no requiera la carga computacional necesaria en otros modelos habitualmente empleados. Material y método. Se ha modelado el tejido cardíaco como un autómata celular, cada uno de cuyos elementos adopta estados discretos en función de su estado previo y del de las células vecinas siguiendo unas reglas sencillas. La activación se contempla como un proceso probabilístico y se ajusta mediante el fenómeno de restitución, mientras la repolarización se modela como un proceso determinista. Finalmente, las corrientes celulares se calculan utilizando un potencial de acción prototipo, lo que permite simular los electrogramas virtuales monopolares y bipolares en cualquier punto del espacio. Resultados. Se ha conseguido reproducir frentes planos de activación, propagación de un estímulo focal y reentradas estables e inestables en 2 dimensiones, con sus electrogramas correspondientes. El modelo es particularmente adecuado para simular los fenómenos asociados a la curvatura de los frentes, y permite reproducir la conducción fibrilatoria y los rotores estables en 2 y 3 dimensiones. Conclusiones. Aunque el modelo de autómata celular probabilístico desarrollado es sencillo y no requiere cargas computacionales elevadas, es capaz de simular de forma realista fenómenos complejos de gran interés en electrofisiología

Introduction and objectives. Mathematical models of cardiac electrical activity may help to elucidate the electrophysiological mechanisms involved in the genesis of arrhythmias. The most realistic simulations are based on reaction-diffusion models and involve a considerable computational burden. The aim of this study was to develop a computer model of cardiac electrical activity able to simulate complex electrophysiological phenomena but free of the large computational demands required by other commonly used models. Material and method. A cellular automata system was used to model the cardiac tissue. Each individual unit had several discrete states that changed according to simple rules as a function of the previous state and the state of the neighboring cells. Activation was considered as a probabilistic process and was adjusted using restitution curves. In contrast, repolarization was modeled as a deterministic phenomenon. Cell currents in the model were calculated with a prototypical action potential that allowed virtual monopolar and bipolar electrograms to be simulated at any point in space. Results. Reproducible flat activation fronts, propagation from a focal stimulus, and reentry processes that were stable and unstable in two dimensions (with their corresponding electrograms) were obtained. The model was particularly suitable for the simulation of the effects observed in curvilinear activation fronts. Fibrillatory conduction and stable rotors in two- and three-dimensional substrates were also obtained. Conclusions. The probabilistic cellular automata model was simple to implement and was not associated with a high computational burden. It provided a realistic simulation of complex phenomena of interest in electrophysiology

[Prognosis of presyncope in patients with structural heart disease]. / Pronóstico del presíncope en pacientes con cardiopatía estructural.

INTRODUCTION AND OBJECTIVES: Few data are available on the prognosis of presyncope in patients with structural heart disease. The aim of this study was to compare the clinical characteristics and long-term prognosis of patients with structural heart disease admitted for presyncope or syncope in the cardiology department of a tertiary hospital. METHODS: We reviewed the medical records of 449 patients (65% men, mean age 66.8 [13.1] years) with structural heart disease admitted because of syncope (n = 272) or presyncope (n = 177) during the period from 1992 to 1998. Clinical and demographic variables were analyzed and the final diagnosis was classified according to European Society of Cardiology criteria. The follow-up (available in 97.1% of patients) consisted of a personal interview with the patient or a review of the medical records and an interview with the relatives of the patients who had died. RESULTS: Both groups had similar demographic and clinical characteristics, except for the presence of atrial fibrillation on admission, which was more common in the presyncope group. Previous syncopal episodes were more frequent in patients admitted for syncope. The mechanism of the episode was considered arrhythmic in 25.7% of the patients with syncope and 22.0% of those in the presyncope group (P=.37). After a mean follow-up of 57.4 [30.5 months the survival curves were similar for both groups and no significant differences were found regarding the causes of death or the rate of sudden death. CONCLUSIONS: The clinical characteristics and the long-term prognosis in patients with structural heart disease admitted to a cardiology department for presyncope are similar to those of patients admitted for syncope. This suggests that the approach to diagnosis and risk stratification should be similar in both groups of patients.

[Impact of primary angioplasty on the indication for implantable cardiac defibrillator in patients with myocardial infarction]. / Impacto de la angioplastia primaria en la indicación de desfibrilador implantable en pacientes con infarto de miocardio.

INTRODUCTION AND OBJECTIVES: Implantable cardiac defibrillators (ICD) have been shown to improve survival in patients with myocardial infarctionand LVEF < 0.30 or LVEF < 0.40 + nonsustained ventricular tachycardia + inducible sustained arrhythmias. However, these risk stratification criteria have not been evaluated in patients who are candidates for primary percutaneous transluminal coronary angioplasty (PTCA). The objective of this study was to assess the impact of both strategies on the indication for ICD in a consecutive series of post-infarction patients treated with primary PTCA. PATIENTS AND METHOD: One hundred and two consecutive patients with myocardial infarction (80 men, mean age 63.6 11.5 years) included in a single-center-based regional program of primary PTCA were included in the study. A 24-h continuous ECG recording was obtained 2 to 6 weeks after the acute event, and LVEF was determined by 2D-echocardiography one month after the infarct. Patients with nonsustained ventricular tachycardia and LVEF < 0.40 underwent programmed ventricular stimulation using a standard protocol. RESULTS: Twenty-two patients (21.6%; 95% CI, 13.6-29.6) showed at least one episode of nonsustained ventricular tachycardia in the 24 h recording. Six of them had LVEF < or = 0.40, and sustained ventricular arrhythmia was induced in 2 out of 5. LVEF < or = 0.30 was found in 3 patients, none of whom had nonsustained ventricular tachycardia. Thus, 5 patients had an indication for ICD according to either of the two risk stratification criteria. CONCLUSIONS: The prevalence of nonsustained ventricular tachycardia in post-infarction patients treated with primary PTCA is high. However, because most of them have preserved ventricular function, primary prevention with an ICD is indicated in approximately 5% of the population.

Impacto de la angioplastia primaria en la indicación de desfibrilador implantable en pacientes con infarto de miocardio / Impact of primary angioplasty on the indication for implantable cardiac defibrillator in patients with myocardial infarction

Introducción y objetivos. El desfibrilador implantable mejora la supervivencia en pacientes postinfarto de miocardio con a) fracción de eyección <= 0,30 y b) fracción de eyección <= 0,40, taquicardias ventriculares no sostenidas y arritmias ventriculares inducibles. Estos criterios no han sido evaluados en el contexto de la angioplastia primaria. El objetivo del estudio es evaluar el impacto de ambos criterios en las indicaciones de desfibrilador en pacientes con infarto revascularizados con angioplastia primaria. Pacientes y método. Se estudió a 102 pacientes postinfarto (80 varones; edad, 63,6 ñ 11,5 años) incluidos en un programa regional de angioplastia primaria. Se realizó un registro Holter de 24 h entre las semanas 2 y 6 postinfarto, al mes, y se estimó la fracción de eyección por ecocardiografía practicando estimulación ventricular programada en el grupo con fracción de eyección <= 0,40 y taquicardia ventricular no sostenida. Resultados. Un total de 22 pacientes (21,6 por ciento; intervalo de confianza [IC] del 95 por ciento, 13,6-29,6) presentaron taquicardia ventricular no sostenida en el Holter. Seis de ellos tuvieron fracción de eyección <= 0,40, siendo inducibles 2 de 5 en el estudio electrofisiológico. La fracción de eyección fue <= 0,30 en 3 pacientes, ninguno de los cuales presentó taquicardia ventricular no sostenida. En total, 5 pacientes (4,9 por ciento) tuvieron indicación de desfibrilador aplicando alguno de los 2 criterios. Conclusiones. La prevalencia de taquicardia ventricular no sostenida en pacientes con infarto tratados con angioplastia primaria es elevada. Sin embargo, la mayoría tiene una función ventricular conservada, por lo que la prevención primaria con desfibrilador estaría indicada en un 5 por ciento aproximadamente utilizando los criterios evaluados en este estudio (AU)